Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current efforts centers on targeting the underlying pathophysiology of MSA. One avenue under investigation involves pharmacological interventions to modulate the